Search Results 1191-1200 of 16131 for pharmacogenetics
The purpose of this study is to analyze if levels of glycoprotein non-metastatic melanoma protein B be elevated in patients with LAM.. Participation eligibility.
The Memory Disorders Lab led by Neill R. Graff-Radford, M.D., at Mayo Clinic studies biomarkers to identify hereditary factors that lead to dementia.
Led by Dr. Sharp, faculty and staff in the Biomedical Ethics Research Program at Mayo Clinic study ethical issues in medicine & biomedical science.
About this study. The purpose of this study is to determine the prevalence, diagnostic accuracy and predictors of antinueronal antibody positivity in serum ...
This study is being conducted in order to better understand the biology of scleromyxedema in hope of discovering markers that might give diagnostic and ...
The purpose of this study is to assess arm activity in the free living environment before and after treatment of a brachial plexus injury. The information ...
Gastrointestinal cancers. Gastrointestinal neoplasia. Gut failure. Hepatology and liver transplant. Inflammatory bowel disease. Liver and bile duct cancer.
Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, ...
Faculty members from Mayo Clinic Center for Regenerative Biotherapeutics develop regenerative therapies to rebuild health from within patients' own bodies.
Acquired brain disorder · Autoimmune neurological disorder · Brain aneurysm · Brain cancer · Brain tumor · Chronic illness · Concussion · Degenerative brain disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact.